Poor Sensitivity of Fecal Gluten Immunogenic Peptides and Serum Antibodies to Detect Duodenal Mucosal Damage in Celiac Disease Monitoring
A lifelong gluten-free diet (GFD) is the only current treatment for celiac disease (CD), but strict compliance is complicated. Duodenal biopsies are the “gold standard” method for diagnosing CD, but they are not generally recommended for disease monitoring. We evaluated the sensitivity and specifici...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/13/1/98 |
id |
doaj-712824f6f969441ba37ec21ba3eaf407 |
---|---|
record_format |
Article |
spelling |
doaj-712824f6f969441ba37ec21ba3eaf4072020-12-31T00:02:20ZengMDPI AGNutrients2072-66432021-12-0113989810.3390/nu13010098Poor Sensitivity of Fecal Gluten Immunogenic Peptides and Serum Antibodies to Detect Duodenal Mucosal Damage in Celiac Disease MonitoringEmilio J. Laserna-Mendieta0María José Casanova1Ángel Arias2Laura Arias-González3Pedro Majano4Luis Alberto Mate5Carlos Humberto Gordillo-Vélez6Mirella Jiménez7Teresa Angueira8Emilia Tébar-Romero9María Jesús Carrillo-Ramos10María Ángeles Tejero-Bustos11Javier P. Gisbert12Cecilio Santander13Alfredo J. Lucendo14Department of Gastroenterology, Hospital General de Tomelloso, 13700 Tomelloso, SpainDepartment of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), 28006 Madrid, SpainInstituto de Investigación Sanitaria Princesa, 28006 Madrid, SpainDepartment of Gastroenterology, Hospital General de Tomelloso, 13700 Tomelloso, SpainInstituto de Investigación Sanitaria Princesa, 28006 Madrid, SpainPathology Department, Hospital General Mancha Centro, 13600 Alcázar de San Juan, SpainInstituto de Investigación Sanitaria Princesa, 28006 Madrid, SpainDepartment of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), 28006 Madrid, SpainDepartment of Gastroenterology, Hospital General de Tomelloso, 13700 Tomelloso, SpainDepartment of Gastroenterology, Hospital General de Tomelloso, 13700 Tomelloso, SpainDepartment of Gastroenterology, Hospital General de Tomelloso, 13700 Tomelloso, SpainDepartment of Gastroenterology, Hospital General de Tomelloso, 13700 Tomelloso, SpainDepartment of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), 28006 Madrid, SpainDepartment of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), 28006 Madrid, SpainDepartment of Gastroenterology, Hospital General de Tomelloso, 13700 Tomelloso, SpainA lifelong gluten-free diet (GFD) is the only current treatment for celiac disease (CD), but strict compliance is complicated. Duodenal biopsies are the “gold standard” method for diagnosing CD, but they are not generally recommended for disease monitoring. We evaluated the sensitivity and specificity of fecal gluten immunogenic peptides (GIPs) to detect duodenal lesions in CD patients on a GFD and compared them with serum anti-tissue transglutaminase (tTG) IgA antibodies. A prospective study was conducted at two tertiary centers in Spain on a consecutive series of adolescents and adults with CD who maintained a long-lasting GFD. Adherence to a GFD and health-related quality of life were scored with validated questionnaires. Mucosal damage graded according to the Marsh–Oberhüber classification (Marsh 1/2/3) was used as the reference standard. Of the 97 patients included, 27 presented duodenal mucosal damage and 70 had normal biopsies (Marsh 0). The sensitivity (33%) and specificity (81%) of GIPs were similar to those provided by the two assays used to measure anti-tTG antibodies. Scores in questionnaires showed no association with GIP, but an association between GIPs and patients’ self-reported gluten consumption was found (<i>p</i> = 0.003). GIP displayed low sensitivity but acceptable specificity for the detection of mucosal damage in CD.https://www.mdpi.com/2072-6643/13/1/98celiac diseasegluten-free diet monitoringMarsh–Oberhüber typegluten immunogenic peptidesanti-tissue transglutaminase antibodiesdiagnostic accuracy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Emilio J. Laserna-Mendieta María José Casanova Ángel Arias Laura Arias-González Pedro Majano Luis Alberto Mate Carlos Humberto Gordillo-Vélez Mirella Jiménez Teresa Angueira Emilia Tébar-Romero María Jesús Carrillo-Ramos María Ángeles Tejero-Bustos Javier P. Gisbert Cecilio Santander Alfredo J. Lucendo |
spellingShingle |
Emilio J. Laserna-Mendieta María José Casanova Ángel Arias Laura Arias-González Pedro Majano Luis Alberto Mate Carlos Humberto Gordillo-Vélez Mirella Jiménez Teresa Angueira Emilia Tébar-Romero María Jesús Carrillo-Ramos María Ángeles Tejero-Bustos Javier P. Gisbert Cecilio Santander Alfredo J. Lucendo Poor Sensitivity of Fecal Gluten Immunogenic Peptides and Serum Antibodies to Detect Duodenal Mucosal Damage in Celiac Disease Monitoring Nutrients celiac disease gluten-free diet monitoring Marsh–Oberhüber type gluten immunogenic peptides anti-tissue transglutaminase antibodies diagnostic accuracy |
author_facet |
Emilio J. Laserna-Mendieta María José Casanova Ángel Arias Laura Arias-González Pedro Majano Luis Alberto Mate Carlos Humberto Gordillo-Vélez Mirella Jiménez Teresa Angueira Emilia Tébar-Romero María Jesús Carrillo-Ramos María Ángeles Tejero-Bustos Javier P. Gisbert Cecilio Santander Alfredo J. Lucendo |
author_sort |
Emilio J. Laserna-Mendieta |
title |
Poor Sensitivity of Fecal Gluten Immunogenic Peptides and Serum Antibodies to Detect Duodenal Mucosal Damage in Celiac Disease Monitoring |
title_short |
Poor Sensitivity of Fecal Gluten Immunogenic Peptides and Serum Antibodies to Detect Duodenal Mucosal Damage in Celiac Disease Monitoring |
title_full |
Poor Sensitivity of Fecal Gluten Immunogenic Peptides and Serum Antibodies to Detect Duodenal Mucosal Damage in Celiac Disease Monitoring |
title_fullStr |
Poor Sensitivity of Fecal Gluten Immunogenic Peptides and Serum Antibodies to Detect Duodenal Mucosal Damage in Celiac Disease Monitoring |
title_full_unstemmed |
Poor Sensitivity of Fecal Gluten Immunogenic Peptides and Serum Antibodies to Detect Duodenal Mucosal Damage in Celiac Disease Monitoring |
title_sort |
poor sensitivity of fecal gluten immunogenic peptides and serum antibodies to detect duodenal mucosal damage in celiac disease monitoring |
publisher |
MDPI AG |
series |
Nutrients |
issn |
2072-6643 |
publishDate |
2021-12-01 |
description |
A lifelong gluten-free diet (GFD) is the only current treatment for celiac disease (CD), but strict compliance is complicated. Duodenal biopsies are the “gold standard” method for diagnosing CD, but they are not generally recommended for disease monitoring. We evaluated the sensitivity and specificity of fecal gluten immunogenic peptides (GIPs) to detect duodenal lesions in CD patients on a GFD and compared them with serum anti-tissue transglutaminase (tTG) IgA antibodies. A prospective study was conducted at two tertiary centers in Spain on a consecutive series of adolescents and adults with CD who maintained a long-lasting GFD. Adherence to a GFD and health-related quality of life were scored with validated questionnaires. Mucosal damage graded according to the Marsh–Oberhüber classification (Marsh 1/2/3) was used as the reference standard. Of the 97 patients included, 27 presented duodenal mucosal damage and 70 had normal biopsies (Marsh 0). The sensitivity (33%) and specificity (81%) of GIPs were similar to those provided by the two assays used to measure anti-tTG antibodies. Scores in questionnaires showed no association with GIP, but an association between GIPs and patients’ self-reported gluten consumption was found (<i>p</i> = 0.003). GIP displayed low sensitivity but acceptable specificity for the detection of mucosal damage in CD. |
topic |
celiac disease gluten-free diet monitoring Marsh–Oberhüber type gluten immunogenic peptides anti-tissue transglutaminase antibodies diagnostic accuracy |
url |
https://www.mdpi.com/2072-6643/13/1/98 |
work_keys_str_mv |
AT emiliojlasernamendieta poorsensitivityoffecalglutenimmunogenicpeptidesandserumantibodiestodetectduodenalmucosaldamageinceliacdiseasemonitoring AT mariajosecasanova poorsensitivityoffecalglutenimmunogenicpeptidesandserumantibodiestodetectduodenalmucosaldamageinceliacdiseasemonitoring AT angelarias poorsensitivityoffecalglutenimmunogenicpeptidesandserumantibodiestodetectduodenalmucosaldamageinceliacdiseasemonitoring AT lauraariasgonzalez poorsensitivityoffecalglutenimmunogenicpeptidesandserumantibodiestodetectduodenalmucosaldamageinceliacdiseasemonitoring AT pedromajano poorsensitivityoffecalglutenimmunogenicpeptidesandserumantibodiestodetectduodenalmucosaldamageinceliacdiseasemonitoring AT luisalbertomate poorsensitivityoffecalglutenimmunogenicpeptidesandserumantibodiestodetectduodenalmucosaldamageinceliacdiseasemonitoring AT carloshumbertogordillovelez poorsensitivityoffecalglutenimmunogenicpeptidesandserumantibodiestodetectduodenalmucosaldamageinceliacdiseasemonitoring AT mirellajimenez poorsensitivityoffecalglutenimmunogenicpeptidesandserumantibodiestodetectduodenalmucosaldamageinceliacdiseasemonitoring AT teresaangueira poorsensitivityoffecalglutenimmunogenicpeptidesandserumantibodiestodetectduodenalmucosaldamageinceliacdiseasemonitoring AT emiliatebarromero poorsensitivityoffecalglutenimmunogenicpeptidesandserumantibodiestodetectduodenalmucosaldamageinceliacdiseasemonitoring AT mariajesuscarrilloramos poorsensitivityoffecalglutenimmunogenicpeptidesandserumantibodiestodetectduodenalmucosaldamageinceliacdiseasemonitoring AT mariaangelestejerobustos poorsensitivityoffecalglutenimmunogenicpeptidesandserumantibodiestodetectduodenalmucosaldamageinceliacdiseasemonitoring AT javierpgisbert poorsensitivityoffecalglutenimmunogenicpeptidesandserumantibodiestodetectduodenalmucosaldamageinceliacdiseasemonitoring AT ceciliosantander poorsensitivityoffecalglutenimmunogenicpeptidesandserumantibodiestodetectduodenalmucosaldamageinceliacdiseasemonitoring AT alfredojlucendo poorsensitivityoffecalglutenimmunogenicpeptidesandserumantibodiestodetectduodenalmucosaldamageinceliacdiseasemonitoring |
_version_ |
1724365541332746240 |